Its growth is attributed to the introduction of new treatments. The chronic obstructive pulmonary disease (COPD) market is ...

((SL Advertiser)) New treatment option for those with chronic obstructive pulmonary disease or COPD. To learn more, go to ...

In the United States, more than 10 million people above the age of 40 live with chronic obstructive pulmonary disease (COPD), a chronic lung disease that limits air flow and causes ...

There are several tests that doctors can use to diagnose and monitor COPD. Let's take a look at what abnormal values for ...

as an add-on maintenance treatment for adults with inadequately controlled chronic obstructive pulmonary disease (COPD) and an eosinophilic phenotype. The approval was based on results from two ...

One of the key highlights was the discussion of Pulmonary Embolism Response Teams (PERT), addressing controversies in PE management and focusing on personalized, patient-centered care.

Respiratory viruses can remain hidden in immune cells in the lungs long after the initial symptoms of an infection have ...

Mucociliary dysfunction, chronic infections with advancing immunosenescence and pulmonary emphysema as seen in COPD may be just as relevant to ACOS. Possible drug targets include receptors of the ...

For people in the MetroWest region living with lung diseases such as chronic obstructive pulmonary disease (COPD), emphysema, ...

and airway remodeling associated with chronic obstructive pulmonary disease (COPD). Selective PDE4 inhibition is proposed to maximize the antiinflammatory effects of PDE inhibition while ...

In the US, more than 10 million people above the age of 40 live with chronic obstructive pulmonary disease, or COPD. We're discussing a new treatment option that may help patients.